TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.30M | 2.34M | 1.76M | 1.05M | 2.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.53M | 8.39M | 6.73M | 5.98M | 6.60M |
| Operating Income | -7.53M | -8.39M | -6.73M | -5.98M | -6.60M |
| Income Before Tax | -7.54M | -6.76M | -7.10M | -9.52M | -6.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.54M | -6.76M | -7.10M | -9.52M | -6.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.54M | -6.76M | -7.10M | -9.52M | -6.66M |
| EBIT | -7.53M | -8.39M | -6.73M | -5.98M | -6.60M |
| EBITDA | -7.51M | -8.37M | -6.71M | -5.96M | -6.58M |
| EPS Basic | -0.13 | -0.13 | -0.14 | -0.21 | -0.15 |
| Normalized Basic EPS | -0.08 | -0.10 | -0.08 | -0.08 | -0.09 |
| EPS Diluted | -0.13 | -0.13 | -0.14 | -0.21 | -0.15 |
| Normalized Diluted EPS | -0.08 | -0.10 | -0.08 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 60.01M | 53.00M | 50.67M | 44.56M | 43.40M |
| Average Diluted Shares Outstanding | 60.01M | 53.00M | 50.67M | 44.56M | 43.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.03% | -0.03% | -0.03% | -0.02% | -0.03% |